Objective. The aim of the present study is to describe the general characteristics of a cohort of patients with early arthritis in Argentina.
Introduction
RA is a chronic rheumatic disease of unknown aetiology characterized by polyarticular and symmetrical inflammation of small and large joints, with potential systemic involvement [1, 2] . It affects from 0.2 to 1% of the Caucasian population, mainly in the age group with higher work or productive capacity within society [3, 4] . The attitude to RA prognosis and treatment has significantly changed during the past two decades, and nowadays RA is considered a severe disease [5, 6] . Long-term studies of patients with established RA show that most of them develop progressive disease with severe radiological damage, worsening functional capacity, labour incapacity and significant increase in mortality [7] [8] [9] [10] [11] [12] .
Therefore, in recent years, the RA therapeutic approach has significantly changed, and two fundamental concepts have appeared: 'the window of opportunity' and 'tight disease control' [13] [14] [15] . For early identification of patients, so-called early arthritis clinics appeared in Europe and the USA allowing establishment of warning guidelines to predict RA development in people with recent-onset arthritis [16] . In September 2008, the first early arthritis clinic in Argentina was established, and it was called CONAART (in Spanish Consorcio Argentino de Artritis Temprana -Argentine Consortium for Early Arthritis). The purpose of this study is to describe the general characteristics of patients included therein.
Materials and methods
CONAART is an initiative of seven rheumatology centres in Argentina. Its purpose is the early identification and treatment of patients with arthritis. Internists, general practitioners and orthopaedists were encouraged to refer patients with clinical suspicion of arthritis. For this purpose, some programmes of medical education, headed by a rheumatologist, related to the importance of early referral and treatment of these patients were provided to them. Likewise, an education programme for the community was communicated through oral and written press to promote early spontaneous consultation. Each centre established a system to see these patients beside the regular consultation in outpatient clinics. In this system, patients with potential arthritis could call by phone to an exclusive number, or appear at the centre, where they were initially attended by non-medical personnel trained to carry out the first screening filter according to pre-defined inclusion criteria, and later, patients were questioned and examined by a rheumatologist. Patients who on the first visit had at least one swollen joint and symptoms lasting <2 years were entered into the database. Socio-demographic data, family history, clinical characteristics of the disease and DAS of 28 joints (DAS-28) [17] were collected. At each visit, patients completed self-questionnaires on functional capacity, disease activity and quality of life (QoL). All these questionnaires, HAQ [18] , HAQ-II [19] , Rheumatoid Arthritis Disease Activity Index (RADAI) [20] and Rheumatoid Arthritis Quality of Life (RAQoL) [21] have been previously validated in Spanish and adapted to the culture of our country. Blood samples were collected to determine ESR, CRP, RF by nephelometry, antibodies to CCP2 (anti-CCP2) by ELISA (Genesis Diagnostics, London, UK) and other immunological and general laboratory studies deemed necessary by the physician. Hand-and feet X-rays were taken and labour characteristics and pharmaco-economic data such as monthly income and disease-related direct and indirect costs were assessed at initial visit. Patient's follow-up is performed quarterly, and the physician must reassess the diagnosis at each visit. No pre-defined treatment protocol is in place. The treatment protocol is determined by the acting physician. All data were entered online with software specially designed for this study. All patients gave their written consent for taking part in the study and the study was approved by the ethics committee of each participating centre.
Statistical analysis
Database information was imported into SPSS for statistical analysis. Continuous variables with no normal distribution were transformed into logarithm or square root for multivariate analysis. Categorical variables were compared by chi-squared test or Fisher's test and continuous variables by Student's t-test, Mann-Whitney and analysis of variance (ANOVA) (Bonferroni's and Tukey's tests were used for post hoc analysis). Anti-CCP2 cut-off value for RA diagnosis in our population was determined by receiver operator characteristic (ROC) curves. A multiple logistic regression analysis to find variables associated with development of RA was used. Odds ratios (ORs) and the corresponding 95% CI were calculated. P < 0.05 was considered to be statistically significant.
Results
Up to June 2009, 413 patients were included, out of which 327 (79.2%) were female and 86 (20.8%) were male, with a mean age of 49 years and a mean duration of symptoms of 6 months by the time they entered into the study. Mean formal time of education was 10 years, 36.3% were affiliated to a social health insurance, 14% had pre-paid health insurance and the rest of them did not have any health insurance. Patients with private health insurance had higher mean monthly income compared with patients without health insurance [$2840 (2671) vs 2350 (1780) Argentinean pesos, respectively], better functional capacity [HAQ 0.76 (0.8) vs 1.16 (0.7), respectively] and better QoL [RAQoL 11.1 (9) vs 15.5 (8), respectively; P = 0.008]. No other differences were found between these two extreme social class groups. Table 1 shows the main diagnosis fulfilled (according to ACR criteria or in the case of UA, by physician criteria) by those patients included after a median follow-up time of 6 months. As 85% of patients had RA or UA, analysis and comparisons 
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Early arthritis cohort in Argentina only included these two main statistically relevant groups of patients. Table 2 shows comparison of the main variables between these groups. It must be noted that differences were independent of demographic characteristics as they were comparable between the two groups. Patients with RA exhibited significantly worse activity, functional capacity and QoL than patients with UA.
In the analysis by ROC curves, the best cut-off point for anti-CCP2 in our population for RA diagnosis was 15 IU. As shown in Table 3 , RF was more sensitive and less specific than anti-CCP2.
In the multivariate analysis, the main variables significantly associated with RA were positivity for RF (OR 14.7; CI 95% 3.7, 57.8) and the presence of anti-CCP2 (cut-off 15 IU; OR 3.47; CI 95% 1.5, 7.8) (Table 4) . Ninety-four patients were unemployed: 51 (54.3%) due to their arthritis; 25 (26.6%) were retired; 9 (9.6%) lost their employment due to other causes; and, in 9 cases, unemployment reasons were not recorded.
In general, unemployment frequency was comparable between UA and RA (24.4 vs 26.5%), as well as unemployment due to the illness 50 vs 59%, respectively. Unemployed patients showed more disease activity and worse functional capacity and QoL than employed patients (DAS-28 5.7 vs 4.7; HAQ 1.51 vs 0.84; RAQoL 19.6 vs 12.2; P = 0.0001 in all cases). In the multivariate analysis, higher age, worse functional capacity and higher disease activity were the main determinants of unemployment, regardless of diagnosis and after adjusting for gender and disease duration (Table 5) .
Finally, patients were divided into quartiles based on symptom duration. Comparisons of disease activity (DAS-28), functional capacity (HAQ, RADAI), QoL (RAQoL) and unemployment were performed between patients in the shortest quartile (symptom duration <6 months) and patients in the highest quartile (symptom duration >18 months) ( Table 6 ).
All patients with RA started specific therapy with DMARDs within 6 months of disease onset. Among DMARDs, the most frequently used was MTX in 180/183 (98.3%) patients.
Discussion
In recent years, various studies have shown that better results in the short and in the long term [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] are directly related to earlier and more aggressive RA therapy. Several studies such as combination therapy for rheumatoid arthritis (COBRA) [30] , Finnish rheumatoid arthritis combination (FIN-RACo) [31, 32] and treatment strategies for rheumatoid arthritis (BeST) [14] showed that early treatment with DMARDs, not later than 4 months from symptom onset, resulted in higher rates of remission and less radiological damage [31] . Still more remarkably, from the point of view of social impact, controlling the disease within the first months resulted in lower indirect costs [32] . Therefore, this gives rise to the window of opportunity [15] concept. Its duration could not be accurately defined; nevertheless, the present treatment strategy is based on the concept 'the earlier, the better' [33, 34] . The best study to evidence this fact is PROMPT (The PRObable rheumatoid arthritis: Methotrexate versus Placebo Treatment). This study showed that treatment with MTX in patients with UA positive for anti-CCP antibodies caused a delay in the appearance of RA and reduced the advance of radiological damage [35] .
Early arthritis clinics arose as a strategy to recruit patients as early as possible [16, 36] . These clinics vary as regards design and inclusion criteria, from patients with arthritis with <3 months of evolution [37, 38] to a maximum of 2 years of symptom onset [39] . These cohorts enabled better identification of RA and of its clinical, functional and pharmaco-economical consequences [16] . However, in many cases, extrapolation of these data to other populations with a different culture, health system and socio-economic level is not appropriate.
In our country, a study performed in 1994 by the study group for RA of the Sociedad Argentina de Reumatología (Argentine Rheumatology Society) showed that the median delay of patients with RA in consulting the rheumatologist and starting specific treatment with DMARDs was 14 months [inter-quartile range (IQR) 2.5-24 months; Casellini et al. (data not published)]. Within this context, CONAART was established in September 2008. This is a joint initiative of seven rheumatology centres in Argentina and it was developed based on the model of the early arthritis clinic of the University of Leiden (Holland) [40] .
In our population, most frequent diagnosis were RA and UA, similar to what happened in other cohorts, where their percentage ranges from 19 and 50% to 20 and 54%, respectively [37, [40] [41] [42] [43] [44] . Our patients with RA exhibited worse activity parameters, functional capacity, QoL and a higher percentage of RF and positive anti-CCP2. The latter two parameters, in turn, were the sole variables 
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Early arthritis cohort in Argentina significantly associated with RA development in the short term. Several differences between patients who progressed to RA and those who remain as UA were observed in our population. Similar differences in other studies allowed the design of different prognosis scores, which are very useful in daily practice to identify those patients more likely to evolve to RA, and thus requiring rapid and intensive treatment [45] [46] [47] .
Due to autoantibody sensitivity variation according to the cut-off value used, we identified which was the most adequate one in our population to differentiate RA from UA. A cut-off value of 15 IU showed a sensitivity to identify RA of 77.3% with a specificity of 78.5%. This sensitivity is higher when compared with other cohorts with similar inclusion criteria [48] .
It is important to mention the social impact of early arthritis in Argentina, as we note a general unemployment frequency of 26.5%, similar to other cohorts of early arthritis around the world [49] . As expected, unemployed patients exhibited worse activity, functional capacity and QoL parameters. Nevertheless, these differences were related to the presence of arthritis and not to the specific diagnosis. This suggests the importance of early diagnosis and early treatment of patients with arthritis, regardless of their diagnosis, so that they can return to work, thus minimizing the disease economic impact.
These are the first data obtained by CONAART. Although our patients with UA have been followed up for a limited period of time, this analysis allowed us to learn the characteristics of patients with early arthritis in Argentina. It must be noted that one of the main objectives of the programme has been attained, as there was a reduction in the average delay in consultation to a rheumatologist and in treating the disease with disease-modifying drugs to only 6 months. This demonstrates the importance of early arthritis clinics as an early method to identify and treat these patients.
Rheumatology key messages
. Patients who develop arthritis should be referred quickly to a rheumatologist. . Early arthritis clinics are a useful tool for diagnosis and treatment of patients at high risk of developing RA. . Functional disability depends on the presence of arthritis rather than a specific diagnosis. 
